The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 20, 2022

Filed:

Oct. 06, 2017
Applicant:

The Board of Trustees of the Leland Stanford Junior University, Stanford, CA (US);

Inventors:

Tzuhua Lin, Stanford, CA (US);

Jukka Pajarinen, Stanford, CA (US);

Stuart B. Goodman, Stanford, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A01N 63/00 (2020.01); A61K 38/20 (2006.01); A61P 21/00 (2006.01); A61P 19/02 (2006.01); A61P 3/10 (2006.01); A61P 29/00 (2006.01); A61P 19/10 (2006.01); A61K 9/00 (2006.01); A61K 35/28 (2015.01); A61K 38/18 (2006.01); A61K 38/19 (2006.01); C12N 15/86 (2006.01); C12N 5/0775 (2010.01); C12N 5/09 (2010.01); C07K 14/54 (2006.01); C07K 14/47 (2006.01); A61K 35/12 (2015.01); C12Q 1/6897 (2018.01);
U.S. Cl.
CPC ...
A61K 38/2026 (2013.01); A61K 9/0019 (2013.01); A61K 35/28 (2013.01); A61K 38/18 (2013.01); A61K 38/1825 (2013.01); A61K 38/1841 (2013.01); A61K 38/1866 (2013.01); A61K 38/195 (2013.01); A61K 38/20 (2013.01); A61K 38/204 (2013.01); A61K 38/2066 (2013.01); A61K 38/2073 (2013.01); A61K 38/2086 (2013.01); A61P 3/10 (2018.01); A61P 19/02 (2018.01); A61P 19/10 (2018.01); A61P 21/00 (2018.01); A61P 29/00 (2018.01); C07K 14/4705 (2013.01); C07K 14/5406 (2013.01); C12N 5/0663 (2013.01); C12N 5/0693 (2013.01); C12N 15/86 (2013.01); A61K 2035/124 (2013.01); C12N 2501/2304 (2013.01); C12N 2501/60 (2013.01); C12N 2510/00 (2013.01); C12N 2529/10 (2013.01); C12N 2740/15043 (2013.01); C12Q 1/6897 (2013.01);
Abstract

Provided are compositions and methods for production of anti-inflammatory cytokines, growth factors, or chemokines. Provided are nucleic acids (e.g., expression vectors) that include an NFκB inflammation response element operably linked to a nucleotide sequence encoding an anti-inflammatory cytokine (e.g., IL-4). In some cases, the nucleic acid is an expression vector selected from: a linear expression vector, a circular expression vector, a plasmid, and a viral expression vector. Also provided are cells (e.g., mesenchymal stem cells—MSCs) comprising a nucleic acid that includes an NFκB inflammation response element operably linked to a nucleotide sequence encoding an anti-inflammatory cytokine. In some cases, the nucleic acid is integrated into the cell's genome. Also provided are methods for treating an individual having an inflammation-associated ailment, which can include administering an MSC to the individual, where the MSC includes an NFκB inflammation response element operably linked to a nucleotide sequence encoding an anti-inflammatory cytokine.


Find Patent Forward Citations

Loading…